LIPOCINE INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
LIPOCINE INC. (LPCN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 271.50 thousand shares for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2015-11-12
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-09-30 was 83.00K shares, a 71.79% decline year-over-year.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-06-30 was 188.50K shares, a 3041.67% increase year-over-year.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2014-12-31 was 6.00K shares, a 91.24% decline year-over-year.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 337.69K shares, a 4.61% decline from fiscal 2013.
- LIPOCINE INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 354.03K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2015-09-30 | 83.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 271.50K shares derived: sum of 2 quarters · filed 2015-11-12 | 271.50K shares 10-Q · filed 2015-11-12 | 277.50K shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | 188.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | 188.50K shares 10-Q · filed 2015-08-11 | 194.50K shares derived: sum of 3 quarters · filed 2015-08-11 | 488.69K shares derived: sum of 4 quarters · filed 2015-08-11 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-07 | 6.00K shares derived: sum of 2 quarters · filed 2015-05-07 | 300.19K shares derived: sum of 3 quarters · filed 2015-05-07 | 306.19K shares derived: sum of 4 quarters · filed 2015-05-07 |
| 2014-12-31 | 6.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | 300.19K shares derived: sum of 2 quarters · filed 2015-03-11 | 306.19K shares derived: sum of 3 quarters · filed 2015-03-11 | 337.69K shares 10-K · filed 2015-03-11 |
| 2014-09-30 | 294.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 300.19K shares derived: sum of 2 quarters · filed 2014-11-10 | 331.69K shares 10-Q · filed 2014-11-10 | 400.19K shares derived: sum of 4 quarters · filed 2015-03-11 |
| 2014-06-30 | 6.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | 37.50K shares 10-Q · filed 2014-08-13 | 106.00K shares derived: sum of 3 quarters · filed 2015-03-11 | |
| 2014-03-31 | 31.50K shares 10-Q · filed 2014-05-13 | 100.00K shares derived: sum of 2 quarters · filed 2015-03-11 | ||
| 2013-12-31 | 68.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | 354.03K shares 10-K · filed 2015-03-11 | ||
| 2013-09-30 | 285.53K shares 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |